PUMA BIOTECHNOLOGY, INC. Increase (Decrease) in Deferred Leasing Fees
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Increase (Decrease) in Deferred Leasing Fees of $0 for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLeasingFees · last filed 2021-11-04
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in deferred leasing fees for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in deferred leasing fees for the quarter ending 2020-09-30 was $0.00.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in deferred leasing fees for the quarter ending 2020-06-30 was $3.00K.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in deferred leasing fees for the quarter ending 2020-03-31 was $41.00K.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in deferred leasing fees for fiscal 2020 was $44.00K, a 71.43% decline from fiscal 2019.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in deferred leasing fees for fiscal 2019 was $154.00K.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in deferred leasing fees for fiscal 2018 was -$409.00K, a 513.13% decline from fiscal 2017.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in deferred leasing fees for fiscal 2017 was $99.00K.
| Period end | Increase (Decrease) in Deferred Leasing Fees 3 month | Increase (Decrease) in Deferred Leasing Fees 6 month | Increase (Decrease) in Deferred Leasing Fees 9 month | Increase (Decrease) in Deferred Leasing Fees 12 month | Increase (Decrease) in Deferred Leasing Fees 45 month | Increase (Decrease) in Deferred Leasing Fees 48 month |
|---|---|---|---|---|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 | |||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $3.00K derived: sum of 3 quarters · filed 2021-11-04 | $44.00K 10-K · filed 2021-03-01 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $3.00K derived: sum of 2 quarters · filed 2021-11-04 | $44.00K 10-Q · filed 2021-11-04 | $159.00K derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $44.00K 10-Q · filed 2021-08-05 | $159.00K derived: sum of 3 quarters · filed 2021-08-05 | |||
| 2020-03-31 | $41.00K 10-Q · filed 2021-05-06 | $156.00K derived: sum of 2 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $154.00K 10-K · filed 2021-03-01 | ||||
| 2019-09-30 | $39.00K 10-Q · filed 2020-11-05 | |||||
| 2018-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$292.00K derived: sum of 2 quarters · filed 2021-03-01 | -$306.00K derived: sum of 3 quarters · filed 2021-03-01 | -$409.00K 10-K · filed 2021-03-01 | ||
| 2018-09-30 | -$353.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$367.00K derived: sum of 2 quarters · filed 2019-11-07 | -$470.00K 10-Q · filed 2019-11-07 | -$438.00K derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$117.00K 10-Q · filed 2019-08-09 | -$85.00K derived: sum of 3 quarters · filed 2020-02-28 | -$53.00K derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-03-31 | -$103.00K 10-Q · filed 2019-05-10 | -$71.00K derived: sum of 2 quarters · filed 2020-02-28 | -$39.00K derived: sum of 3 quarters · filed 2020-02-28 | -$7.00K derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2017-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $64.00K derived: sum of 2 quarters · filed 2020-02-28 | $96.00K derived: sum of 3 quarters · filed 2020-02-28 | $99.00K 10-K · filed 2020-02-28 | ||
| 2017-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $64.00K derived: sum of 2 quarters · filed 2018-11-05 | $67.00K 10-Q · filed 2018-11-05 | -$154.00K derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $35.00K 10-Q · filed 2018-08-09 | -$186.00K derived: sum of 3 quarters · filed 2019-03-01 | -$623.00K derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $3.00K 10-Q · filed 2018-05-10 | -$218.00K derived: sum of 2 quarters · filed 2019-03-01 | -$655.00K derived: sum of 3 quarters · filed 2019-03-01 | -$4.18M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2016-12-31 | -$221.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$658.00K derived: sum of 2 quarters · filed 2019-03-01 | -$4.18M derived: sum of 3 quarters · filed 2019-03-01 | -$4.11M 10-K · filed 2019-03-01 | ||
| 2016-09-30 | -$437.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$3.96M derived: sum of 2 quarters · filed 2017-11-09 | -$3.89M 10-Q · filed 2017-11-09 | -$3.83M derived: sum of 4 quarters · filed 2018-03-09 | ||
| 2016-06-30 | -$3.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$3.45M 10-Q · filed 2017-08-09 | -$3.40M derived: sum of 3 quarters · filed 2018-03-09 | -$3.36M derived: sum of 4 quarters · filed 2018-03-09 | ||
| 2016-03-31 | $67.00K 10-Q · filed 2017-05-10 | $126.00K derived: sum of 2 quarters · filed 2018-03-09 | $158.00K derived: sum of 3 quarters · filed 2018-03-09 | $145.00K derived: sum of 4 quarters · filed 2018-03-09 | ||
| 2015-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $91.00K derived: sum of 2 quarters · filed 2018-03-09 | $78.00K derived: sum of 3 quarters · filed 2018-03-09 | -$124.00K 10-K · filed 2018-03-09 | ||
| 2015-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $19.00K derived: sum of 2 quarters · filed 2016-11-09 | -$183.00K 10-Q · filed 2016-11-09 | -$361.00K derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$215.00K 10-Q · filed 2016-08-09 | -$393.00K derived: sum of 3 quarters · filed 2017-03-01 | -$377.00K derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | -$202.00K 10-Q · filed 2016-05-10 | -$380.00K derived: sum of 2 quarters · filed 2017-03-01 | -$364.00K derived: sum of 3 quarters · filed 2017-03-01 | -$248.00K derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2014-12-31 | -$178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$162.00K derived: sum of 2 quarters · filed 2017-03-01 | -$46.00K derived: sum of 3 quarters · filed 2017-03-01 | -$153.00K 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $132.00K derived: sum of 2 quarters · filed 2015-11-09 | $25.00K 10-Q · filed 2015-11-09 | $32.00K derived: sum of 4 quarters · filed 2016-02-29 | -$188.00K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $9.00K 10-Q · filed 2015-08-10 | $16.00K derived: sum of 3 quarters · filed 2016-02-29 | $29.00K derived: sum of 4 quarters · filed 2016-02-29 | -$204.00K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | -$107.00K 10-Q · filed 2015-05-11 | -$100.00K derived: sum of 2 quarters · filed 2016-02-29 | -$87.00K derived: sum of 3 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $20.00K derived: sum of 2 quarters · filed 2016-02-29 | -$27.00K 10-K · filed 2016-02-29 | |||
| 2013-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$34.00K 10-Q · filed 2014-11-10 | ||||
| 2013-06-30 | -$47.00K 10-Q · filed 2014-08-11 | |||||
| 2012-12-31 | -$186.00K 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |